Cleveland Clinic challenge seeks promising health IT startups

The Cleveland Clinic’s New Ventures Healthcare Challenge is looking for early-stage health IT companies with promising technologies to disrupt the healthcare market.

“Whether your technology will solve challenges in domains such as payment reform, access to care, consumer engagement, operational efficiency or a domain we haven’t even thought of, we want to hear about it—and we want the world to know about it,” according to the challenge website.

Competing companies are required to submit a 90-second video clip that answers the following questions: What is unique about your technology?; Why do you feel this technology will be game changing?; How big will the impact be?; and What are your company’s strategic goals?

Businesses that are selected to advance then must schedule an online presentation to the New Ventures Healthcare Challenge Steering Committee, which includes representatives from Cleveland Clinic, IBM, HealthXL and HIMSS.

The finalists will present their “groundbreaking” IT at the Medical Innovation Summit in Ohio this October.

The winning company will receive a free consultation from commercialization experts at Cleveland Clinic Innovations and its Innovation Advisory Board, and have an opportunity to showcase its product to a select group of Cleveland Clinic caregivers.

Learn more on the website.

 

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.